F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Gut-Liver axis

Page 1 of 1 ( 40 items )
<<
1
>>

1	Microbiota-bile acid crosstalk and hepatic gluconeogenesis after intestinal resection: Revisiting the gut-liver axis for metabolic recovery 4/24/2026 10:11:08 AM \| Browse: 28 \| Download: 116
2	Interplay between intestinal permeability and metabolic dysfunction-associated steatotic liver disease: Could there be a role for extra virgin olive oil consumption? 12/26/2025 10:27:35 AM \| Browse: 97 \| Download: 235
3	Gluten’s silent strike: Unmasking its impact on liver health 12/22/2025 7:43:02 AM \| Browse: 85 \| Download: 327
4	Gut microbiota and metabolic-associated steatosis liver disease: Unveiling mechanisms and opportunities for therapeutic intervention 12/19/2025 8:32:39 AM \| Browse: 183 \| Download: 355
5	Tumor-resident microorganisms as clinical biomarkers in primary liver cancer: A systematic review of current evidence 12/11/2025 8:20:56 AM \| Browse: 134 \| Download: 401
6	Targeting gut microbiota in liver disease: A pharmacological approach for hepatic encephalopathy and beyond 12/5/2025 11:28:03 AM \| Browse: 115 \| Download: 346
7	Uridine diphosphate-glucose 6-dehydrogenase-mediated glucuronidation and its emerging role in gut-liver immune regulation 10/14/2025 7:42:32 AM \| Browse: 125 \| Download: 269
8	Advancing the management of primary biliary cholangitis: From pathogenesis to emerging therapies 10/11/2025 9:30:02 AM \| Browse: 153 \| Download: 426
9	Unraveling the gut-liver axis in autoimmune liver disease overlap syndrome: A multi-omics perspective 9/25/2025 3:33:09 AM \| Browse: 195 \| Download: 365
10	Gut-liver axis in diabetes: Mechanisms and therapeutic opportunities 8/5/2025 8:25:47 AM \| Browse: 213 \| Download: 401
11	Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics 6/26/2025 7:27:54 AM \| Browse: 285 \| Download: 748
12	Gut feeling gone wrong: Tangled relationship between disorders of gut-brain interaction and liver disease 5/27/2025 7:04:47 AM \| Browse: 113 \| Download: 528
13	Diagnostic value of alpha-fetoprotein and prothrombin induced by vitamin K absence-II in serum, bile, feces in hepatocellular carcinoma 5/15/2025 10:28:56 AM \| Browse: 213 \| Download: 755
14	Potential mechanisms and therapeutic prospects of the association between Helicobacter pylori infection and metabolic dysfunction-associated steatohepatitis 1/6/2025 8:47:55 AM \| Browse: 250 \| Download: 899
15	Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy 10/31/2024 10:42:49 AM \| Browse: 171 \| Download: 536
16	Sepsis-associated liver injury: Mechanisms and potential therapeutic targets 10/31/2024 10:39:35 AM \| Browse: 245 \| Download: 750
17	Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications and therapeutic potentials 10/25/2024 3:02:14 AM \| Browse: 173 \| Download: 853
18	Importance of the gut microbiota in the gut-liver axis in normal and liver disease 6/20/2024 3:42:22 AM \| Browse: 253 \| Download: 889
19	Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis 5/22/2024 11:33:24 AM \| Browse: 327 \| Download: 1093
20	Impact of microplastics and nanoplastics on liver health: Current understanding and future research directions 3/6/2024 6:10:51 AM \| Browse: 369 \| Download: 941
21	Epidemiology of small intestinal bacterial overgrowth 6/7/2023 6:39:13 AM \| Browse: 664 \| Download: 1066
22	Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients 3/17/2023 6:20:53 AM \| Browse: 481 \| Download: 1129
23	Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies 1/4/2023 5:53:01 AM \| Browse: 567 \| Download: 1554
24	Intestinal microbiota in the treatment of metabolically associated fatty liver disease 10/27/2022 4:55:04 AM \| Browse: 713 \| Download: 1363
25	Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial 8/26/2022 9:51:35 AM \| Browse: 668 \| Download: 1861
26	Gut dysbiosis and body composition in cirrhosis 6/23/2022 2:39:01 PM \| Browse: 853 \| Download: 2801
27	Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis 3/11/2022 9:47:59 AM \| Browse: 755 \| Download: 2360
28	Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma 2/22/2022 9:25:37 AM \| Browse: 824 \| Download: 2064
29	Overview of the microbiota in the gut-liver axis in viral B and C hepatitis 11/19/2021 11:15:33 AM \| Browse: 699 \| Download: 1509
30	Probiotics in hepatology: An update 9/22/2021 8:09:41 AM \| Browse: 916 \| Download: 2139
31	Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis 8/5/2021 2:37:04 PM \| Browse: 763 \| Download: 2212
32	Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis 5/20/2021 3:14:20 PM \| Browse: 1047 \| Download: 2878
33	Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis 5/10/2021 7:46:10 AM \| Browse: 907 \| Download: 2803
34	Role of gut microbiota <Italic>via</Italic> the gut-liver-brain axis in digestive diseases 10/28/2020 8:26:09 AM \| Browse: 879 \| Download: 2195
35	Gut-liver axis signaling in portal hypertension 10/21/2019 9:37:00 AM \| Browse: 1197 \| Download: 2767
36	Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation 9/7/2019 4:43:36 AM \| Browse: 1314 \| Download: 2743
37	Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 1/26/2019 11:40:14 AM \| Browse: 1469 \| Download: 3166
38	Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia 12/2/2015 12:01:00 PM \| Browse: 1783 \| Download: 2314
39	Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease 11/17/2014 3:13:00 PM \| Browse: 1564 \| Download: 1875
40	Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection 10/29/2014 7:34:00 PM \| Browse: 1290 \| Download: 1966

Page 1 of 1 ( 40 items )
<<
1
>>

1	Microbiota-bile acid crosstalk and hepatic gluconeogenesis after intestinal resection: Revisiting the gut-liver axis for metabolic recovery 4/24/2026 10:11:08 AM \| Browse: 28 \| Download: 116
2	Interplay between intestinal permeability and metabolic dysfunction-associated steatotic liver disease: Could there be a role for extra virgin olive oil consumption? 12/26/2025 10:27:35 AM \| Browse: 97 \| Download: 235
3	Gluten’s silent strike: Unmasking its impact on liver health 12/22/2025 7:43:02 AM \| Browse: 85 \| Download: 327
4	Gut microbiota and metabolic-associated steatosis liver disease: Unveiling mechanisms and opportunities for therapeutic intervention 12/19/2025 8:32:39 AM \| Browse: 183 \| Download: 355
5	Tumor-resident microorganisms as clinical biomarkers in primary liver cancer: A systematic review of current evidence 12/11/2025 8:20:56 AM \| Browse: 134 \| Download: 401
6	Targeting gut microbiota in liver disease: A pharmacological approach for hepatic encephalopathy and beyond 12/5/2025 11:28:03 AM \| Browse: 115 \| Download: 346
7	Uridine diphosphate-glucose 6-dehydrogenase-mediated glucuronidation and its emerging role in gut-liver immune regulation 10/14/2025 7:42:32 AM \| Browse: 125 \| Download: 269
8	Advancing the management of primary biliary cholangitis: From pathogenesis to emerging therapies 10/11/2025 9:30:02 AM \| Browse: 153 \| Download: 426
9	Unraveling the gut-liver axis in autoimmune liver disease overlap syndrome: A multi-omics perspective 9/25/2025 3:33:09 AM \| Browse: 195 \| Download: 365
10	Gut-liver axis in diabetes: Mechanisms and therapeutic opportunities 8/5/2025 8:25:47 AM \| Browse: 213 \| Download: 401
11	Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics 6/26/2025 7:27:54 AM \| Browse: 285 \| Download: 748
12	Gut feeling gone wrong: Tangled relationship between disorders of gut-brain interaction and liver disease 5/27/2025 7:04:47 AM \| Browse: 113 \| Download: 528
13	Diagnostic value of alpha-fetoprotein and prothrombin induced by vitamin K absence-II in serum, bile, feces in hepatocellular carcinoma 5/15/2025 10:28:56 AM \| Browse: 213 \| Download: 755
14	Potential mechanisms and therapeutic prospects of the association between Helicobacter pylori infection and metabolic dysfunction-associated steatohepatitis 1/6/2025 8:47:55 AM \| Browse: 250 \| Download: 899
15	Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy 10/31/2024 10:42:49 AM \| Browse: 171 \| Download: 536
16	Sepsis-associated liver injury: Mechanisms and potential therapeutic targets 10/31/2024 10:39:35 AM \| Browse: 245 \| Download: 750
17	Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications and therapeutic potentials 10/25/2024 3:02:14 AM \| Browse: 173 \| Download: 853
18	Importance of the gut microbiota in the gut-liver axis in normal and liver disease 6/20/2024 3:42:22 AM \| Browse: 253 \| Download: 889
19	Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis 5/22/2024 11:33:24 AM \| Browse: 327 \| Download: 1093
20	Impact of microplastics and nanoplastics on liver health: Current understanding and future research directions 3/6/2024 6:10:51 AM \| Browse: 369 \| Download: 941
21	Epidemiology of small intestinal bacterial overgrowth 6/7/2023 6:39:13 AM \| Browse: 664 \| Download: 1066
22	Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients 3/17/2023 6:20:53 AM \| Browse: 481 \| Download: 1129
23	Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies 1/4/2023 5:53:01 AM \| Browse: 567 \| Download: 1554
24	Intestinal microbiota in the treatment of metabolically associated fatty liver disease 10/27/2022 4:55:04 AM \| Browse: 713 \| Download: 1363
25	Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial 8/26/2022 9:51:35 AM \| Browse: 668 \| Download: 1861
26	Gut dysbiosis and body composition in cirrhosis 6/23/2022 2:39:01 PM \| Browse: 853 \| Download: 2801
27	Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis 3/11/2022 9:47:59 AM \| Browse: 755 \| Download: 2360
28	Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma 2/22/2022 9:25:37 AM \| Browse: 824 \| Download: 2064
29	Overview of the microbiota in the gut-liver axis in viral B and C hepatitis 11/19/2021 11:15:33 AM \| Browse: 699 \| Download: 1509
30	Probiotics in hepatology: An update 9/22/2021 8:09:41 AM \| Browse: 916 \| Download: 2139
31	Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis 8/5/2021 2:37:04 PM \| Browse: 763 \| Download: 2212
32	Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis 5/20/2021 3:14:20 PM \| Browse: 1047 \| Download: 2878
33	Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis 5/10/2021 7:46:10 AM \| Browse: 907 \| Download: 2803
34	Role of gut microbiota <Italic>via</Italic> the gut-liver-brain axis in digestive diseases 10/28/2020 8:26:09 AM \| Browse: 879 \| Download: 2195
35	Gut-liver axis signaling in portal hypertension 10/21/2019 9:37:00 AM \| Browse: 1197 \| Download: 2767
36	Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation 9/7/2019 4:43:36 AM \| Browse: 1314 \| Download: 2743
37	Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 1/26/2019 11:40:14 AM \| Browse: 1469 \| Download: 3166
38	Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia 12/2/2015 12:01:00 PM \| Browse: 1783 \| Download: 2314
39	Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease 11/17/2014 3:13:00 PM \| Browse: 1564 \| Download: 1875
40	Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection 10/29/2014 7:34:00 PM \| Browse: 1290 \| Download: 1966